Health Care Professionals' Expectations of the Medical Science Liaison: A Blinded Survey

Therapeutic Innovation and Regulatory Science

Volumn 47, Issue 2, 2013, Pages 203-208

  Moss, Robert J ^a   Black, Jimmy ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

field based; key opinion leader; medical liaison; pharmaceutical industry; survey

Indexed keywords

ARTICLE; DIABETES MELLITUS; DRUG INDUSTRY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MEDICAL SCIENCE LIAISON; MEDICINE; PRIORITY JOURNAL; TELECONSULTATION;

EID: 84877622578     PISSN: 21684790     EISSN: 21649200     Source Type: Journal    
DOI: 10.1177/2168479012470649     Document Type: Article

References (6)

1. Morgan DK,Domann DE,Collins GE, et al.History and evolution of field-based medical programs.Drug Inf J. 2000;34:1049-1052.
2. Cram DL,Chandler M,Chin J.Medical science liaisons of the future: a position against overspecialization.Med Sci Liaison Q. 2006;4 (2):.
3. Marrone CM,Bass JL,Klinger CK.Survey of medical liaison practices across the pharmaceutical industry.Drug Inf J. 2007;41:457-470.
4. Marrone CM,Bass JL,Klinger CK.Survey of medical liaison practices 2: assessing training techniques and demonstrating value of medical liaisons.Drug Inf J. 2008;42:67-80.
5. Bass JL,Marrone CM,Klinger C.Survey of medical liaison practices 3: assessing practice trends across the pharmaceutical industry.Drug Inf J. 2010;44:535-549.
6. Klinger CK,Marrone CM,Bass JL.Medical liaison survey 4: assessing tools used by medical liaisons, clinical trial involvement, and career strategies.Drug Inf J. 2010;44:551-567.